Navigation Links
Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013
Date:4/25/2013

/p>

8,921

6,890

42,389

20,167Income tax provision

2,223

2,184

14,930

7,076Net income

$
,698

$
4,706

$
27,459

$
3,091Net income per share:  Basic net income per share

$
.30

$
.22

$
.25

$
.59  Diluted net income per share

$
.30

$
.21

$
.23

$
.58Shares used in the calculation of net income per share:  Weighted average common shares outstanding - basic

22,081

21,693

21,946

22,084  Weighted average common shares outstanding - diluted

22,486

22,070

22,381

22,462 ABAXIS, INC.Condensed Consolidated Balance Sheets(Unaudited and in thousands)March 31,March 31,20132012Current assets: Cash and cash equivalents

$
54,910

$
45,843 Short-term investments

23,354

21,689 Receivables, net

40,005

30,694 Inventories

26,786

19,597 Prepaid expenses and other current assets

3,319

5,423 Net deferred tax assets, current

4,589

4,151Total current assets 

152,963

127,397Long-term investments

17,000

23,442Investment in unconsolidated affiliate

2,613

2,626Property and equipment, net

25,330

24,296Intangible assets, net

3,122

3,990Net deferred tax assets, non-current

643

-Other assets

92

85Total assets

$
201,763

$
81,836Current liabilities: Accounts payable

$
8,123

$
,381 Accrued payroll and related expenses

6,261

6,336 Accrued taxes

440

266 Other accrued liabilities

2,838

1,991 Deferred revenue


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
2. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
3. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
4. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
5. Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013
6. Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
7. Abaxis Declares Special Cash Dividend of $1.00 Per Share
8. Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
9. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
10. Abaxis, Inc. to Present at the Stephens Fall Investment Conference
11. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... 15, 2011 Millennium HealthCare Inc. ... LLP, a Public Company Accounting Oversight Board (PCAOB) accounting ... KBL, LLP provides a combination of technology, ... businesses. Their professionals maintain an entrepreneurial spirit and a ...
... US, LLC ("Astellas") recently named Percival Barretto-Ko as ... a new position added to the company,s leadership ... Barretto-Ko will be responsible for corporate planning, business ... government affairs. "This realignment brings key ...
Cached Medicine Technology:Millennium HealthCare Inc. Engages KBL, LLP 2Astellas Expands Leadership Team With Senior Vice President of Corporate Strategy and Government Affairs 2
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley ... recognized in the 2015 Aster Awards national competition for a marketing communications campaign ... City and surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form ... been advanced, upgraded, made more effective and less intrusive and painful. Leading these ... Enlargement Center. Dr. Loria currently stands as the only doctor in the United ...
(Date:7/31/2015)... New York, NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The ... this photo op. , Glancing out of the window, he recalled that his equipment ... 215 Chrystie Street tower, he jumped out of bed. , The photo speaks ...
(Date:7/31/2015)... ... , ... Ticket Down is a reputable source of authentic USA vs. ... will face the Australia Women's National Team in two separate friendly contests. The ... and the second match will occur in Birmingham, Alabama at Legion Field. These ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in conjunction with their Victory Tour ... 5-2. Carli Lloyd from the USA team was awarded the Golden Ball as the ...
Breaking Medicine News(10 mins):Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... are calling on the Federal Government to fund a new ... ,Rotavirus puts 10,000 Australian children in hospital each year, ... at doctors' surgeries with symptoms of acute diarrhoea and vomiting. ... aged six to 32 weeks, is only available by private ...
... to be "alarmingly dismal" with over 180 million urban poor ... says an industry analysis. ,At least 300 additional ... up annually to cater to the needs of 215 million ... Chambers of Commerce and Industry of India (ASSOCHAM). ...
... information management device by Intel and Motion Computing, is no ... that it is starting to ship the device to hospitals ... with patients, do their jobs on the move while remaining ... an impressive array of features such as a camera, RFID ...
... tobacco industry memo from 1969. For half a century, the ... cancer. Now, with that effort long since failed, cigarette producers ... to manufacture doubt. ,"The tobacco industry is now ... everyone knew but no one had proof," said Robert N. ...
... its distinguishing shape? Shape may be formed by cell movement, ... of which react to// influences from the local environment. Initially, ... to develop into cardiac chambers. ,In a new ... Heidi Auman, Deborah Yelon, and colleagues found, by using transgenic ...
... experts Fred R. Volkmar, M.D., and Ami Klin are part ... an individual gene and a// region of a chromosome that ... are published online in Nature Genetics and also will be ... on the largest autism genome scan done to date. The ...
Cached Medicine News:Health News:Call for Rotavirus Vaccine Funding 2Health News:Urban Poor in Dire Need of Proper Healthcare: Report 2Health News:Tobacco Companies Obstructed Science 2Health News:Tobacco Companies Obstructed Science 3Health News:Autism Gene Identified by Yale and Global Consortium 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: